Its a tool that, when combined with provider guidance and healthy habits, can make sustainable weight loss and improved overall health achievable. At Northwest Face & Body, every patient is evaluated holistically
Wegovy contains semaglutide, a clinically proven medication that belongs to the GLP-1 receptor agonist class
Loss of Appetite : While appetite suppression is a desired effect, it may also be accompanied by a general decrease in food cravings
For patients preferring in office injections our nurses can administer the injections for ongoing care
By this point, the body has had sixteen weeks to progressively adapt to triple-agonist activity
More specifically, orforglipron is a potent partial GLP-1 RA which is biased towards G-protein activation over to -arrestin recruitment at the GLP-1 receptor [23]